No Data
No Data
TD Cowen Maintains DarioHealth(DRIO.US) With Buy Rating, Maintains Target Price $5
TD Cowen analyst Charles Rhyee maintains $DarioHealth(DRIO.US)$ with a buy rating, and maintains the target price at $5.According to TipRanks data, the analyst has a success rate of 47.4% and a total
Express News | DarioHealth Corp: Rick Anderson Will Step Down in His Role as President
Express News | DarioHealth Corp: Appoints Steven Nelson as Its Chief Commercial Officer of Co
Express News | DarioHealth Corp: Dedicated C-Level Positions Will Be Established for Each Core Function, Reporting Directly to CEO
Express News | DarioHealth Corp: President Role Will Be Eliminated
Express News | Empowering Commercial Expansion: DarioHealth Announces Strategic Reorganization and Appoints Inaugural Chief Commercial Officer
No Data
TrytosaveabitOP : Corrected-DarioHealth Q1 Revenue USD 5.8 Million (Corrects Amount)